COVID-19 vaccines and thrombosis—roadblock or dead-end street?

K Lundstrom, D Barh, BD Uhal, K Takayama… - Biomolecules, 2021 - mdpi.com
Two adenovirus-based vaccines, ChAdOx1 nCoV-19 and Ad26. COV2. S, and two mRNA-
based vaccines, BNT162b2 and mRNA. 1273, have been approved by the European …

SARS-CoV-2 vaccines: types, working principle, and its impact on thrombosis and gastrointestinal disorders

S Khare, Niharika, A Singh, I Hussain, NB Singh… - Applied Biochemistry …, 2023 - Springer
In the current scenario of the coronavirus pandemic caused by Severe Acute Respiratory
Syndrome Coronavirus 2 (SARS-CoV-2), considerable efforts have been made to control the …

[PDF][PDF] SARS‑CoV‑2 Vaccines: Types, Working Principle, and Its Impact on Thrombosis and Gastrointestinal Disorders

NB Singh, S Singh - academia.edu
In the current scenario of the coronavirus pandemic caused by Severe Acute Respiratory
Syndrome Coronavirus 2 (SARS-CoV-2), considerable efforts have been made to control the …

Double‐Gene Copromoting Expression Analysis in tPA/GH Transgenic Goat Mammary Epithelial Cells and Thrombolytic Activity of tPA In Vitro

S Song, Y Luo, Z Liu, D Li, J Ye… - BioMed Research …, 2022 - Wiley Online Library
Human tissue‐plasminogen activator (tPA) is a thrombolytic drug widely used in the
treatment of stroke, pulmonary thrombosis, acute myocardial infarction, and other thrombotic …

Drugs that affect blood coagulation, fibrinolysis and hemostasis

SC Choi, D Tompkins, J Wilczynski, CE Kulig - Side Effects of Drugs Annual, 2021 - Elsevier
This chapter reviewed 2020 publications that identify side effects of drugs that affect blood
coagulation, fibrinolysis, and hemostasis. Publications on warfarin, apixaban, dabigatran …